Press Release
PSP001 (PEGIL29 Chimera) IND submission (FDA) |
Date:2021-02-05 17:07:25 | Visits: |
|
Prev:Peginterferon Lambda Investigator-Sponsored Studies in COVID-19 Initiating Next:PSP001 received Safe-to-proceed Letter by FDA |
PSP001 (PEGIL29 Chimera) IND submission (FDA) |
Date:2021-02-05 17:07:25 | Visits: |
|
Prev:Peginterferon Lambda Investigator-Sponsored Studies in COVID-19 Initiating Next:PSP001 received Safe-to-proceed Letter by FDA |